Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Sinovac Biotech Ltd (SVA)

Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F Business Wire - Mon May 1, 2023

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2022 annual report on Form 20-F with the U.S. Securities...

SVA.TO : 0.2400 (-2.04%)
SVA : 6.47 (-0.31%)
Sinovac Amends Shareholder Rights Plan Business Wire - Wed Feb 22, 2023

Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its shareholder...

SVA.TO : 0.2400 (-2.04%)
SVA : 6.47 (-0.31%)
SINOVAC Reports Unaudited First Half of 2022 Financial Results Business Wire - Thu Dec 29, 2022

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended...

SVA.TO : 0.2400 (-2.04%)
SVA : 6.47 (-0.31%)
SINOVAC Varicella Vaccine Prequalified by WHO Business Wire - Thu Nov 3, 2022

Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that it received prequalification from the World Health...

SVA.TO : 0.2400 (-2.04%)
SVA : 6.47 (-0.31%)
SINOVAC to Showcase Products at CPHI Frankfurt Business Wire - Fri Oct 28, 2022

Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company will participate in CPHI Frankfurt, one of...

SVA.TO : 0.2400 (-2.04%)
SVA : 6.47 (-0.31%)
SINOVAC DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Sinovac Biotech Ltd. and Encourages Investors to Contact the Firm Business Wire - Fri Oct 14, 2022

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Sinovac Biotech Ltd. (“Sinovac” or the “Company”)...

SVA.TO : 0.2400 (-2.04%)
SVA : 6.47 (-0.31%)
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Sinovac Biotech Ltd. (SVA) Investors of Class Action Deadline Against 1Globe Capital LLC and to Actively Participate Business Wire - Fri Oct 14, 2022

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against 1Globe Capital LLC (“1Globe”) and certain of its officers, on behalf of...

SVA.TO : 0.2400 (-2.04%)
SVA : 6.47 (-0.31%)
SVA FINAL DEADLINE MONDAY: ROSEN, A LEADING NATIONAL FIRM, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA PR Newswire - Tue Oct 11, 2022

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11,...

SVA.TO : 0.2400 (-2.04%)
SVA : 6.47 (-0.31%)
SVA FINAL DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVA Business Wire - Mon Oct 10, 2022

WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11, 2016 and February 22, 2019, both dates inclusive (the “Class...

SVA.TO : 0.2400 (-2.04%)
SVA : 6.47 (-0.31%)
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA PR Newswire - Tue Oct 4, 2022

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11,...

SVA.TO : 0.2400 (-2.04%)
SVA : 6.47 (-0.31%)

Barchart Exclusives

1 Energy Dividend Stock That Just Hiked Its Cash Flow Forecast Barchart - Thu Nov 7, 6:30PM CST
Analysts are optimistic about this dividend-paying energy company, which raised its cash flow forecast after surging LNG demand pushed it past Q3 expectations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot